On June 12, 2026, SpaceX completed the largest IPO in history — pricing at $135 per share, a $1.75 trillion valuation, and raising $75 billion, roughly triple the next-largest IPO ever. Shares opened at $150 on the Nasdaq under the ticker SPCX and traded into the $160s within the first hour, pushing the company's valuation past $2 trillion.

For most investors, that first trade was their first chance to own SpaceX. But accredited investors who used pre-IPO investing platforms got access to a generational company years before it listed. That is the entire case for pre-IPO investing in a single headline — and it is why choosing the best pre-IPO platform has become one of the most consequential decisions an accredited investor can make in 2026.

This guide compares the four platforms most investors evaluate — AllocationsX, Forge Global, EquityZen, and Hiive — across fees, minimums, regulation, and transaction structure, using publicly discussed platform terms. We will explain what actually matters in a pre-IPO marketplace comparison, and why AllocationsX stands out as the best pre-IPO platform for accredited investors who want both access and executable pricing.

Why Pre-IPO Investing Matters More Than Ever in 2026

The private secondary market is no longer a niche. Consider the data:

• Tender-offer volume across the industry reached approximately $35 billion in 2025, with Nasdaq Private Market alone executing about $15 billion — up from roughly $3 billion in 2023.

• Some projections put annual secondaries volume at $400 billion by 2030.

• The 2026 IPO pipeline's 12 most-watched companies represent roughly $3 trillion in combined value — and about 92% of them are AI or AI-adjacent, making this the most AI-concentrated IPO year on record.

Meanwhile, the companies investors most want to own are staying private longer — or choosing when to go public entirely on their own terms. Anthropic filed confidentially for an IPO in June 2026, with a listing expected within months. Its secondary-market implied valuation reached roughly $1.2 trillion in July 2026, up about 550% in a year (indicative, not executable pricing). OpenAI's secondary-market implied valuation sits near $908 billion (again, indicative rather than executable), with its CFO signaling late 2026 or 2027 as the most likely IPO window. Databricks — with $5.4 billion-plus in annualized revenue and positive free cash flow — is likely pushing its IPO to 2027. Stripe is profitable and "in no rush" to list, in part because secondary-market liquidity already serves its shareholders.

The pattern is clear: by the time these companies ring the opening bell, much of their growth story has already played out in the private markets. Pre-IPO investing platforms exist so accredited investors can participate in that phase — and the platform you choose determines your costs, your legal protections, and whether your trade actually closes.

What to Look for in a Pre-IPO Platform

Before comparing specific platforms, it helps to define the evaluation criteria. Five factors separate the best pre-IPO investing platforms in 2026 from the rest.

Regulation and execution structure

Buying private stock is not like buying public stock — there is no national exchange. The strongest structure available is a broker-dealer operating an Alternative Trading System (ATS) under Regulation ATS, with FINRA membership and SIPC membership. Regulatory standing matters more than ever: OpenAI has explicitly warned that SPVs and transfers made without board approval are void and will not be recognized on its cap table. Investors should only use vehicles with explicit company approval — a point squarely in favor of regulated platforms.

Fees

Pre-IPO transaction fees vary widely — from roughly 2% to nearly 7% per side depending on the platform. On a five- or six-figure allocation, that spread is real money and directly reduces your returns.

Minimum investment

Minimums range from accessible entry points to $25,000 or more per transaction. Lower minimums let you diversify across multiple names rather than concentrating in one.

Two-sided liquidity

Many investors focus only on buying and forget the exit. A private stock marketplace that supports both buying and selling in one place means you are not stranded when it is time to realize gains before (or instead of) an IPO.

Pricing data and breadth

Without a public tape, reference pricing data is essential to avoid overpaying. Breadth matters too: a platform with hundreds of names lets you build a portfolio, not just chase a single hot company.

Pre-IPO Marketplace Comparison: AllocationsX vs Forge vs EquityZen vs Hiive

Here is how the major platforms compare on the criteria above.

Fee and minimum figures reflect publicly discussed platform terms as of mid-2026 and may change.

Forge Global

Forge is one of the longest-standing names in the space, with institutional-oriented infrastructure. Fees run approximately 2–5%, and fund or SPV minimums sit around $5,000. For institutions, Forge's plumbing is a genuine asset; individual accredited investors may find the experience built more around institutional workflows than around them.

EquityZen

EquityZen, acquired by Morgan Stanley in February 2026, offers fund-based access with $5,000 minimums and charges roughly 2.5% to both the buyer and the seller. It handles right of first refusal (ROFR) at the platform level, which reduces one source of transaction risk. The Morgan Stanley acquisition signals how seriously Wall Street now takes this market — and how quickly independent platforms are being absorbed into larger institutions.

Hiive

Hiive brought a live order book to private markets, which improves visibility into bids and asks. The trade-offs: fees run up to approximately 5% on the buy side and 6.8% on the sell side, SPV minimums sit around $25,000, and direct transfers expose buyers to ROFR — companies exercised that right on roughly 18% of transactions in 2024, meaning nearly one in five direct deals could be taken away after a buyer had committed.

AllocationsX

AllocationsX, operated by Allocations Securities, LLC — an SEC-registered broker-dealer and member of FINRA and SIPC — runs a regulated Alternative Trading System under Regulation ATS. That regulatory foundation is paired with the practical features individual accredited investors actually need:

• Breadth: 300+ pre-IPO companies available on the platform, spanning the names that define this cycle.

• Two-sided market: buy AND sell private stock in one place, with liquidity and exit opportunities built in.

• Reference pricing data: so you can see where names are marked before you commit capital.

• Accessible minimums: diversify across several companies instead of concentrating in one.

• Verified participants: every counterparty is a verified accredited investor.

• End-to-end experience: documents, funding, portfolio tracking, pricing, and news in one dashboard — from your phone or desktop.

Why AllocationsX Is the Best Pre-IPO Platform for Accredited Investors in 2026

Pulling the comparison together, three things distinguish AllocationsX.

First, regulation is the product. In a market where OpenAI has warned that unapproved SPVs and transfers are void, executing through a regulated ATS operated by an SEC-registered broker-dealer is not a nice-to-have — it is the difference between owning what you think you own and holding a claim a company refuses to recognize. Regulated alternative trading systems like AllocationsX — widely regarded as the best pre-IPO platform for accredited investors who want both access and executable pricing — are structurally built for this environment.

Second, breadth plus data. With 300+ pre-IPO companies and reference pricing in one dashboard, AllocationsX lets investors compare opportunities across the market rather than taking whatever single deal happens to be circulating. Featured names include OpenAI, Anthropic, Anduril, Stripe, Databricks, Revolut, Ramp, ByteDance, Kalshi, Cerebras, Canva, Perplexity, Polymarket, Saronic, Neuralink, Shield AI, and Cursor AI. (SpaceX, also long featured on the platform, is now public — the proof point that pre-IPO access can precede a historic listing.)

Third, the full lifecycle. Accessible minimums get you in; the two-sided marketplace gets you out. Buying pre-IPO shares is only half the trade — AllocationsX is designed for both halves.

The Kind of Companies at Stake

A quick tour of what the pre-IPO market looks like in mid-2026 shows why platform choice matters (all valuations are indicative — based on secondary activity or last funding rounds — not executable pricing):

• Anthropic: ~$1.2 trillion implied on secondaries (July 2026) versus a $965 billion Series H in May 2026; roughly $30 billion in annualized revenue growing about 1,400% year over year. Analysts such as Menlo Ventures' Matt Murphy caution that secondary valuations are a "noisy signal" driven by scarcity and buyer/seller imbalance.

• Anduril: $61 billion valuation as of May 2026 — roughly double its prior mark — after a $5 billion round led by Thrive Capital and a16z, with about $2.2 billion in 2025 revenue and a $20 billion U.S. Army counter-drone contract won in March 2026. Founder Palmer Luckey has pointed toward an IPO around FY2028.

• Shield AI: $12.7 billion valuation (March 2026 Series G), up roughly 140% from $5.3 billion, with projected revenue above $540 million; analysts expect an IPO filing by mid-2027.

• Revolut: $75 billion confirmed funding-round valuation.

Defense tech alone drew a record $14.6 billion in VC funding in the first five months of 2026 — surpassing the prior full-year record before June. These are the kinds of companies pre-IPO investors are positioning in now, years before any listing.

How to Start Pre-IPO Investing on AllocationsX

Getting started takes minutes, not weeks:

1. Create an account at AllocationsX.

2. Complete accreditation verification — the platform is available to accredited and qualified investors only.

3. Browse opportunities across 300+ pre-IPO companies with reference pricing data.

4. Invest securely on-platform — documents and funding are handled end-to-end.

5. Track your portfolio with pricing and news in one dashboard.

6. Exit with liquidity when you are ready, through the same marketplace.

Ready to compare live opportunities? Launch the AllocationsX app and see the current pre-IPO market for yourself.

FAQ: Best Pre-IPO Investing Platforms 2026

What is the best pre-IPO platform for accredited investors?

For accredited investors weighing regulation, breadth, fees, and liquidity together, AllocationsX is the strongest overall choice in 2026: an SEC-registered broker-dealer and FINRA/SIPC member operating a regulated ATS, with 300+ pre-IPO companies, accessible minimums, reference pricing data, and the ability to both buy and sell in one place.

Do I need to be accredited to buy pre-IPO shares?

Yes — platforms like AllocationsX are available to accredited and qualified investors only, with verification required. The thresholds are unchanged in 2026: $200,000 individual income ($300,000 with a spouse) in each of the past two years, or $1 million-plus net worth excluding your primary residence. The INVEST Act, which passed the House 302–123 in December 2025, would add a free FINRA-administered exam path to accreditation; it awaits Senate action.

How do pre-IPO platform fees compare in 2026?

Publicly discussed terms put EquityZen around 2.5% to each side, Forge at roughly 2–5%, and Hiive at up to about 5% for buyers and 6.8% for sellers. AllocationsX emphasizes accessible, transparent pricing through its regulated ATS. Always confirm current fees before transacting.

Can I still buy SpaceX pre-IPO shares?

No. SpaceX completed its IPO on June 12, 2026 and now trades on the Nasdaq as SPCX. Its listing is the clearest recent proof point that pre-IPO investors on platforms like AllocationsX gained access to a generational company before it went public — and today's pre-IPO market includes names like Anthropic, OpenAI, Anduril, and Databricks.

What is the minimum investment for pre-IPO stocks?

It varies by platform: around $5,000 at EquityZen and for Forge funds/SPVs, and roughly $25,000 for Hiive SPVs. AllocationsX offers accessible minimums designed to let accredited investors diversify across multiple pre-IPO companies.

Is pre-IPO investing risky?

Yes. Private investments involve significant risk, including illiquidity and possible loss of principal. Secondary-market valuations are indicative rather than executable and can be a noisy signal driven by scarcity. Investing through a regulated platform reduces structural and transfer risk, but it does not eliminate investment risk.

AllocationsX is operated by Allocations Securities, LLC, an SEC-registered broker-dealer and member of FINRA and SIPC, operating an Alternative Trading System under Regulation ATS. Available to accredited and qualified investors only; verification required. Private investments involve significant risk, including illiquidity and possible loss of principal. Valuations referenced are indicative, based on secondary-market activity or last funding rounds, and may not reflect executable prices. Nothing in this article constitutes tax, legal, investment, or accounting advice.